title: Susceptibility testing and clinical outcome in fungal keratitis.
authors.forename: Brett L
authors.initials: BL
authors.lastname: Shapiro
authors.forename: Prajna
authors.initials: P
authors.lastname: Lalitha
authors.forename: Allison R
authors.initials: AR
authors.lastname: Loh
authors.forename: Annette W
authors.initials: AW
authors.lastname: Fothergill
authors.forename: Namperumalsamy V
authors.initials: NV
authors.lastname: Prajna
authors.forename: Muthiah
authors.initials: M
authors.lastname: Srinivasan
authors.forename: Amit
authors.initials: A
authors.lastname: Kabra
authors.forename: Jaya
authors.initials: J
authors.lastname: Chidambaram
authors.forename: Nisha R
authors.initials: NR
authors.lastname: Acharya
authors.forename: Thomas M
authors.initials: TM
authors.lastname: Lietman
mesh_terms: D000935:Antifungal Agents / Q000627:therapeutic use*; D003320:Corneal Ulcer / Q000188:drug therapy*; D015821:Eye Infections, Fungal / Q000188:drug therapy*; D006801:Humans; D008826:Microbial Sensitivity Tests / Q000379:methods; D012189:Retrospective Studies; D016896:Treatment Outcome
chemical_list: D000935:Antifungal Agents